MK0457 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Colorectal Cancer and Other Advanced Solid Tumors (0457-001)

NCT00099346 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer
Advanced Solid Tumors

Interventions

DRUG: MK0457, VX-680 (Aurora Kinase Inhibitor)

Sponsor

Merck Sharp & Dohme LLC